Alnylam

Insider Ownership

Name Relationship / Title Current Shares Trading Activity
allen patricia l Officer 0 View
Ausiello,, Dennis A. M.d. Director 3,500 View
Bonney, Michael W. Director 4,000 View
Clarke, John K. Director 0 View
Fanucci, Marsha H. Director 0 View
greene barry e Officer 88,584 View
gros david-alexandre c Officer 1,000 View
keating laurie Officer 11,500 View
koblan kenneth s Officer 357 View
Maraganore,, John M. Ph.d. Officer 149,710 View
mason michael Officer 708 View
novartis ag Beneficial Owner (10% or more) 4,051,002 View
Paul, Steven M. M.d. Director 1,000 View
pyott david e i Director 27,900 View
reid laurence Officer 18,103 View
sanofi Beneficial Owner (10% or more) 10,554,134 View
Schimmel,, Paul R. Ph.d. Director 306,996 View
Sharp,, Phillip A. Ph.d. Director 266,899 View
Starr, Kevin P. Director 0 View
vaishnaw akshay Officer 11,535 View
vincent james l Director 0 View

Stock transaction information provided by EDGAR Online. Alnylam Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.